Lack of dynamics in the MabA active site kills the enzyme activity: practical consequences for drug-design studies
{{output}}
The MabA protein from Mycobacterium tuberculosis is a validated drug target. Previous structural studies of this protein showed dynamic behaviour in the catalytic site and described motion between an open 'active' holo form (with NADP) and a closed 'inactive' ... ...
